Understanding Australian Pharmacists’ Perceptions on the Utilisation of Oral 5-HT3 Antagonists as Pharmacist-Only Anti-Emetics in Comparison to Oral D2 Antagonists
Journal of Pharmacy Practice · 2024
DOI: 10.1177/08971900241236379 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Pharmacy Practice, 2024. Verfasst von Aiden Hendry und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Health Sciences, University of South Australia, Adelaide, AU-SA, Australia. Hauptthemen laut MEDLINE: Pharmacists, Antiemetics, Serotonin 5-HT3 Receptor Antagonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
To investigate the perception of community pharmacists on the down-scheduling of 5-HT3 antagonists to pharmacist-only-medicine for treatment of acute nausea and/or vomiting in Australia.
Methods
A nationwide anonymous survey targeting Australian community pharmacists was conducted from April to May 2023. Responses were collected and analysed quantitively or qualitatively, where appropriate. Key findings: Participants reported that 5-HT3 antagonists were effective at treating nausea and/or vomiting and would likely recommend their use. Training is required to manage supply due to concerns related to their side effects.
Conclusion
Participants supported down-scheduling of 5-HT3 antagonists for the treatment of nausea and/or vomiting in Australia. A pilot study on the provision of 5-HT3 antagonists by pharmacists is recommended as is the development of guidelines for pharmacist-only supply before down-scheduling is considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Health Sciences, University of South Australia, Adelaide, AU-SA, Australia.
- Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, AU-SA, Australia.
- Health and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, AU-SA, Australia.
ORCID-Profile: Wern Chern Chai
Zitieren
APA
Hendry, A., Janetzki, J., & Chai, W. C. (2024). Understanding Australian Pharmacists’ Perceptions on the Utilisation of Oral 5-HT3 Antagonists as Pharmacist-Only Anti-Emetics in Comparison to Oral D2 Antagonists. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900241236379
Vancouver
Hendry A, Janetzki J, Chai WC. Understanding Australian Pharmacists’ Perceptions on the Utilisation of Oral 5-HT3 Antagonists as Pharmacist-Only Anti-Emetics in Comparison to Oral D2 Antagonists. Journal of Pharmacy Practice. 2024. doi:10.1177/08971900241236379
BibTeX
@article{Hendry2024,
author = {Hendry, Aiden and Janetzki, Jack and Chai, Wern Chern},
title = {Understanding Australian Pharmacists’ Perceptions on the Utilisation of Oral 5-HT3 Antagonists as Pharmacist-Only Anti-Emetics in Comparison to Oral D2 Antagonists},
journal = {Journal of Pharmacy Practice},
year = {2024},
doi = {10.1177/08971900241236379}
}
EUVIMED